Hemosiderosis other imaging findings: Difference between revisions
Jump to navigation
Jump to search
m Template |
|||
(3 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Chromium]] and [[technetium]] based perfusion scans may be helpful in the [[diagnosis]] of [[IPH]]. Findings on these perfusion scans suggestive of IPH include: abnormal [[pulmonary]] [[uptake]] 12-24 hours after the [[injection]] in patients with [[pulmonary hemorrhage]]. | |||
==Other imaging findings== | ==Other imaging findings== | ||
[[Chromium]] and [[technetium]] based perfusion scans may be helpful in the [[diagnosis]] of [[IPH]]. Findings on these perfusion scans suggestive of IPH include: | |||
*Abnormal [[pulmonary]] [[uptake]] 12-24 hours after the [[injection]] in patients with [[pulmonary hemorrhage]]. | |||
==References== | ==References== |
Latest revision as of 04:29, 28 September 2020
Hemosiderosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hemosiderosis other imaging findings On the Web |
American Roentgen Ray Society Images of Hemosiderosis other imaging findings |
Risk calculators and risk factors for Hemosiderosis other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Chromium and technetium based perfusion scans may be helpful in the diagnosis of IPH. Findings on these perfusion scans suggestive of IPH include: abnormal pulmonary uptake 12-24 hours after the injection in patients with pulmonary hemorrhage.
Other imaging findings
Chromium and technetium based perfusion scans may be helpful in the diagnosis of IPH. Findings on these perfusion scans suggestive of IPH include:
- Abnormal pulmonary uptake 12-24 hours after the injection in patients with pulmonary hemorrhage.